Ubs Global Asset Management Americas »

Neurocrine Biosciences shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $83M 599k 137.92
2023-12-31 $81M 618k 131.76
2023-09-30 $66M 589k 112.50
2023-06-30 $58M 569k 101.22
2023-03-31 $58M 569k 101.22
2022-12-31 $65M 543k 119.44
2022-09-30 $55M 514k 106.21
2022-06-30 $49M 498k 97.48
2022-03-31 $48M 516k 93.75
2021-12-31 $30M 350k 85.17
2021-09-30 $26M 274k 95.91
2021-06-30 $25M 257k 97.32
2021-03-31 $41M 425k 97.25
2020-12-31 $55M 568k 96.16
2020-09-30 $55M 568k 96.16
2020-06-30 $66M 541k 122.00
2020-03-31 $41M 479k 86.55
2019-12-31 $55M 512k 107.49
2019-09-30 $37M 408k 90.11
2019-06-30 $37M 439k 84.43
2019-03-31 $36M 411k 88.10
2018-12-31 $27M 380k 71.41
2018-09-30 $20M 164k 122.95
2018-06-30 $36M 363k 98.24
2018-03-31 $32M 380k 82.93
2017-12-31 $36M 465k 77.59
2017-09-30 $32M 520k 61.28
2017-06-30 $23M 500k 46.00
2017-03-31 $26M 595k 43.30
2016-12-31 $22M 578k 38.73
2016-09-30 $30M 600k 50.62
2016-06-30 $28M 618k 45.45
2016-03-31 $25M 628k 39.50
2015-12-31 $35M 612k 56.57
2015-09-30 $25M 614k 39.82
2015-06-30 $38M 797k 47.76
2015-03-31 $35M 890k 39.71
2014-12-31 $22M 960k 22.34
2014-09-30 $15M 929k 15.67
2014-06-30 $13M 890k 14.84
2014-03-31 $14M 890k 16.10
2013-12-31 $6.6M 703k 9.34
2013-09-30 $5.4M 481k 11.32
2013-06-30 $6.3M 471k 13.38